Multi-Center PAMPA Study
Phase 4
176
about 6.5 years
18+
3 sites in MA, NY
What this study is about
This trial is testing guselkumab, a treatment for psoriasis, compared to a placebo. The goal is to see if guselkumab can reduce inflammation and prevent the development of psoriatic arthritis (PsA) in people with high-risk psoriasis.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Guselkumab
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
guselkumab
injection, intravenous
Primary: Change in Musculoskeletal, Power Doppler Ultrasound (MSK-PDUS) Composite Score
Secondary: Change in EuroQol-5D (EQ-5D) Score, Change in Ultrasound (US) Score, Change in the ultrasound composite score of synovitis
Dermatology